Stockscreener 앱 받기
10.54
0.24%
0.025
시간 외 거래:
10.54
전일 마감가:
$10.52
열려 있는:
$10.54
하루 거래량:
2.91M
Relative Volume:
23.69
시가총액:
$353.27M
수익:
-
순이익/손실:
$5.65M
주가수익비율:
62.55
EPS:
0.1685
순현금흐름:
$-414.10K
1주 성능:
+0.24%
1개월 성능:
+0.67%
6개월 성능:
+2.33%
1년 성능:
+5.08%
1일 변동 폭
$10.53
$10.54
1주일 범위
$10.53
$10.54
52주 변동 폭
$10.03
$10.54
Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile
명칭
Drugs Made In America Acquisition Corp
전화
954-870-3104
주소
2 PELICAN DR., FORT LAUDERDALE
Compare DMAA vs LION, XXI, MTAL, UMAC, DMII
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DMAA
Drugs Made In America Acquisition Corp
|
10.54 | 352.43M | 0 | 5.65M | -414.10K | 0.1685 |
LION
Lionsgate Studios Corp
|
10.66 | 3.22B | 2.80B | -224.60M | -1.10M | -0.8751 |
XXI
Twenty One Capital Inc
|
7.40 | 2.55B | 0 | 4.35M | 456.40K | 0.3397 |
MTAL
Metals Acquisition Corp Ii
|
10.01 | 1.01B | 0 | -24.35M | -3.33M | -0.6869 |
UMAC
Unusual Machines Inc
|
15.42 | 668.55M | 11.20M | -19.19M | -23.24M | -0.7527 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.00 | 656.41M | 0 | 0 | 0 | -0.0028 |
Drugs Made In America Acquisition Corp 주식(DMAA)의 최신 뉴스
Drugs Made In America (NASDAQ: DMAA) details SPAC cash, LOI and risks - Stock Titan
Drugs Made in America (DMAA) asks investors to extend SPAC deal deadline - Stock Titan
Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Sees Large Decrease in Short Interest - MarketBeat
Chipmakers Recap: Can Drugs Made In America Acquisition Corp Equity Right sustain earnings growth2026 Performance Recap & Daily Entry Point Trade Alerts - baoquankhu1.vn
Weekly Recap: Is Drugs Made In America Acquisition Corp a momentum stock2026 Stock Rankings & High Conviction Trade Alerts - baoquankhu1.vn
JPMorgan Chase & Co. Buys Shares of 99,690 Drugs Made In America Acquisition Corp. $DMAA - MarketBeat
Aug Chart Watch: What makes Drugs Made In America Acquisition Corp stock attractive today2026 Patterns & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Drugs Made In America Acquisition (NASDAQ:DMAA) Shares Down 0%What's Next? - MarketBeat
Targets Report: Can Drugs Made In America Acquisition Corp Equity Right deliver alphaStop Loss & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Drugs Made In America Acquisition Corp.Rights (NQ: DMAAR - The Chronicle-Journal
Power Analytics Global Corp signed a letter of intent to acquire Drugs Made In America Acquisition Corp. in a reverse merger transaction for $1.0 billion. - marketscreener.com
Drugs Made In America Acquisition Corp. Signs LOI for De-SPAC Merger with Power Analytics Global Corp - Minichart
Drugs Made In America Acquisition II Corp. Unit (DMIIU) Competitors - Meyka
Drugs Made in America SPAC Signs Power Analytics LOI - TipRanks
Drugs Made in America Acquisition Corp. signs LOI for de-SPAC with Power Analytics - Investing.com
Drugs Made In America Acquisition CorpEnters Loi For De-Spac With Power Analytics Global CorpSEC Filing - TradingView — Track All Markets
Drugs Made in America to pursue de-SPAC with Power Analytics Global at ~$1.0B valuation - TradingView — Track All Markets
DMAAR SEC FilingsDrugs Made In Amer Acqutn Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Idea Acquisition Corp.: Performance & Quotes, IACO Stock Price on Nasdaq Exchange - marketscreener.com
Willow Lane Acquisition Corp. II: Performance & Quotes, WLII Stock Price on Nasdaq Exchange - marketscreener.com
Why Is Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) Stock Up Today? - Meyka
Death Cross: Can Drugs Made In America Acquisition Corp Equity Right sustain earnings growth2026 Sector Review & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Chart Watch: Is Drugs Made In America Acquisition Corp Equity Right stock influenced by commodity pricesEarnings Overview Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Drugs Made In America Acquisition II Corp. Announces $1.4 Million Convertible Notes Financing Agreement with Alpha Multi Family Office - Minichart
Drugs Made In America Acquisition II Corp. enters $300,000 convertible note agreement - Investing.com Australia
Drugs Made In America II Issues Interim Convertible Note - TipRanks
Drugs Made In America Acquisition II Finalizes $1.4M Notes Deal, Adds $300K Interim Convertible - TradingView
$300K zero‑interest note backs Drugs Made In America II (NASDAQ: DMII) - Stock Titan
Drugs Made in America Acquisition II Delays Annual Filing - TipRanks
Drugs Made in America Delays Annual Filing - TipRanks
Late 10-K notice — Drugs Made in America (NASDAQ: DMAA) delays FY2025 filing - Stock Titan
DMII (NASDAQ: DMII) files 12b-25—expects to file 10-K by Apr 15, 2026 - Stock Titan
Drugs Made In America Acquisition II Corp.Right (Nasdaq:DMIIR) Stock Quote - The Chronicle-Journal
FitLife Brands, Inc. 2025 Financial Performance: Online & Wholesale Revenue, Margins, and Strategic Initiatives - Minichart
Cambridge Acquisition Corp.: Performance & Quotes, CAQ Stock Price on Nasdaq Exchange - MarketScreener
Sentiment Review: Can WBPRBC stock double in the next year2026 Investor Takeaways & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
DMAAR Stock Price, News & Analysis - Stock Titan
Market Rankings: Is Drugs Made In America Acquisition Corp Equity Rights growth already priced in2026 Fundamental Recap & Reliable Breakout Forecasts - baoquankhu1.vn
Entry Recap: Is Drugs Made In America Acquisition Corp affected by consumer sentimentTrade Volume Summary & Smart Swing Trading Alerts - baoquankhu1.vn
Drugs Made In America Acquisition Corp. issues $100,000 convertible note as part of $500,000 financing - Investing.com Australia
Drugs Made in America (DMAA) seeks shareholder vote to extend SPAC deadline - Stock Titan
Drugs Made In America Signs Financing and Sponsor Deal - TipRanks
Drugs Made In America Acquisition Secures $500,000 Financing; Issues $100,000 Interim Note - TradingView
DMII Stock Price, News & Analysis - Stock Titan
Drugs Made In America Acquisition (NASDAQ: DMAA) adds $500K bridge note and AI-focused target - Stock Titan
HEIGHTS CAPITAL MANAGEMENT, INC's Drugs Made In America Acquisition Corp(DMAA) Holding History - GuruFocus
Take Profit: What analysts say about Drugs Made In America Acquisition Corp Equity Right stockPortfolio Performance Summary & Trade Opportunity Analysis - baoquankhu1.vn
Why Is Drugs Made In America Acquisition II Corp. Unit (DMIIU) Stock Down Today? - Meyka
Why Is Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) Stock Down Today? - Meyka
14,375,000 Ordinary Shares of Drugs Made In America Acquisition II Corp. are subject to a Lock-Up Agreement Ending on 23-MAR-2026. - marketscreener.com
Drugs Made In America Acquisition Corp. announced that it expects to receive $0.5 million in funding from BV Advisory Partners, LLC - marketscreener.com
Drugs Made In America Acquisition Corp (DMAA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.18%
0.00%
자본화:
|
볼륨(24시간):